April 9, 2015
Novo Nordisk Pharma President Claus Eilersen Novo Nordisk Pharma’s long-acting insulin analog Tresiba (insulin degludec) helped the company achieve a turnaround and chalk up NHI-price based sales of a record 99 billion yen in 2014, President Claus Eilersen said on...read more